Search

everythinglearnresearchcommunity

for

Search:↓

Acquired Progressive Kinking of Hair is likely an early sign of male pattern baldness.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Testosterone can slow hair growth in adult monkeys, but a blocker called RU 58841 can counteract this and potentially help hair regrow.

PCOS is a common hormonal disorder in women that can affect skin, fertility, and metabolism, and treatment is tailored to individual needs.

Male hormones can cause hair loss, but treatments like Minoxidil and Finasteride can help, and targeting TGF-B1 could be a future solution.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Male pattern hair loss affects up to 80% of men due to genetics and hormone sensitivity.

Male pattern baldness is caused by certain cells in hair follicles and could potentially be treated by targeting a specific growth factor, TGF-β1.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Balding hair follicles have less growth-promoting factors and more inhibitory factors, leading to hair loss.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Androgens, like testosterone, are crucial for early testicular descent in rats.

2-Methoxyestradiol causes cancer cell death by activating specific pathways, but androgens can block this effect.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Clascoterone cream could be used for other skin conditions affected by hormones.

Hirsutism is abnormal male-pattern hair growth in females due to excess androgens.